[HTML][HTML] Cyclooxygenase 2-regulated genes an alternative avenue to the development of new therapeutic drugs for colorectal cancer

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - frontiersin.org
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - europepmc.org
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

[HTML][HTML] Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - frontiersin.org
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

AM Hidalgo-Estévez, K Stamatakis… - 2020 - digital.csic.es
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

AM Hidalgo-Estevez, K Stamatakis… - Eicosanoids in …, 2021 - books.google.com
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

[HTML][HTML] Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

Cyclooxygenase 2-regulated genes an alternative avenue to the development of new therapeutic drugs for colorectal cancer

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - repositorio.uam.es
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

AM Hidalgo-Estévez, K Stamatakis… - Frontiers in …, 2020 - europepmc.org
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high
mortality rates. Several clinical trials and meta-analyses have determined that the use of …